197 related articles for article (PubMed ID: 33276405)
1. Intrathecal Administration of Nusinersen in Pediatric SMA Patients with and without Spine Deformities: Experiences and Challenges over 3 Years in a Single Center.
Johannsen J; Weiss D; Schlenker F; Groth M; Denecke J
Neuropediatrics; 2021 Jun; 52(3):179-185. PubMed ID: 33276405
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive institutional overview of intrathecal nusinersen injections for spinal muscular atrophy.
Mousa MA; Aria DJ; Schaefer CM; Kaye RD; Abruzzo TA; Bernes SM; Willard SD; Riemann MC; Towbin RB
Pediatr Radiol; 2018 Nov; 48(12):1797-1805. PubMed ID: 30022258
[TBL] [Abstract][Full Text] [Related]
3. Managing intrathecal administration of nusinersen in adolescents and adults with 5q-spinal muscular atrophy and previous spinal surgery.
Mendonça RH; Fernandes HDS; Pinto RBS; Matsui Júnior C; Polido GJ; Silva AMSD; Grossklauss LF; Reed UC; Zanoteli E
Arq Neuropsiquiatr; 2021 Feb; 79(2):127-132. PubMed ID: 33759979
[TBL] [Abstract][Full Text] [Related]
4. Adherence and Persistence to Nusinersen for Spinal Muscular Atrophy: A US Claims-Based Analysis.
Fox D; To TM; Seetasith A; Patel AM; Iannaccone ST
Adv Ther; 2023 Mar; 40(3):903-919. PubMed ID: 36534265
[TBL] [Abstract][Full Text] [Related]
5. Ultrasound-guided cervical puncture for nusinersen administration in adolescents.
Ortiz CB; Kukreja KU; Lotze TE; Chau A
Pediatr Radiol; 2019 Jan; 49(1):136-140. PubMed ID: 30167764
[TBL] [Abstract][Full Text] [Related]
6. Cervical puncture to deliver nusinersen in patients with spinal muscular atrophy.
Veerapandiyan A; Pal R; D'Ambrosio S; Young I; Eichinger K; Collins E; Westesson PL; Kwon J; Ciafaloni E
Neurology; 2018 Aug; 91(7):e620-e624. PubMed ID: 30006410
[TBL] [Abstract][Full Text] [Related]
7. Nusinersen: A Treatment for Spinal Muscular Atrophy.
Claborn MK; Stevens DL; Walker CK; Gildon BL
Ann Pharmacother; 2019 Jan; 53(1):61-69. PubMed ID: 30008228
[TBL] [Abstract][Full Text] [Related]
8. Pediatric SMA patients with complex spinal anatomy: Implementation and evaluation of a decision-tree algorithm for administration of nusinersen.
Carrera-García L; Muchart J; Lazaro JJ; Expósito-Escudero J; Cuadras D; Medina J; Bosch de Basea M; Colomer J; Jimenez-Mallebrera C; Ortez C; Natera-de Benito D; Nascimento A
Eur J Paediatr Neurol; 2021 Mar; 31():92-101. PubMed ID: 33711792
[TBL] [Abstract][Full Text] [Related]
9. Nusinersen for the treatment of spinal muscular atrophy.
Chiriboga CA
Expert Rev Neurother; 2017 Oct; 17(10):955-962. PubMed ID: 28884620
[TBL] [Abstract][Full Text] [Related]
10. Nusinersen: A Review in 5q Spinal Muscular Atrophy.
Hoy SM
CNS Drugs; 2021 Dec; 35(12):1317-1328. PubMed ID: 34850360
[TBL] [Abstract][Full Text] [Related]
11. Nusinersen for Spinal Muscular Atrophy in the United States: Findings From a Retrospective Claims Database Analysis.
Gauthier-Loiselle M; Cloutier M; Toro W; Patel A; Shi S; Davidson M; Bischof M; LaMarca N; Dabbous O
Adv Ther; 2021 Dec; 38(12):5809-5828. PubMed ID: 34713391
[TBL] [Abstract][Full Text] [Related]
12. Intrathecal administration of nusinersen in adolescent and adult SMA type 2 and 3 patients.
Wurster CD; Winter B; Wollinsky K; Ludolph AC; Uzelac Z; Witzel S; Schocke M; Schneider R; Kocak T
J Neurol; 2019 Jan; 266(1):183-194. PubMed ID: 30460449
[TBL] [Abstract][Full Text] [Related]
13. Nusinersen by subcutaneous intrathecal catheter for symptomatic spinal muscular atrophy patients with complex spine anatomy.
Carson VJ; Young M; Brigatti KW; Robinson DL; Reed RM; Sohn J; Petrillo M; Farwell W; Miller F; Strauss KA
Muscle Nerve; 2022 Jan; 65(1):51-59. PubMed ID: 34606118
[TBL] [Abstract][Full Text] [Related]
14. Unilateral interlaminar fenestration on the convex side provides a reliable access for intrathecal administration of nusinersen in spinal muscular atrophy: a retrospective study.
Wang Z; Feng E; Jiao Y; Zhao J; Chen X; Zhang H; Liang J; Li Z; Cui X; Chen W; Shen J
Orphanet J Rare Dis; 2023 Nov; 18(1):369. PubMed ID: 38031122
[TBL] [Abstract][Full Text] [Related]
15. Computed tomography-guided transforaminal lumbar puncture using local anesthesia and a straight 22-gauge spinal needle for intrathecal nusinersen in adults: Findings in 77 procedures.
Cox M; Atsina KB; Ramchand P; Ji J; Sedora-Roman N; Pukenas B
Interv Neuroradiol; 2022 Jun; 28(3):262-265. PubMed ID: 34424100
[TBL] [Abstract][Full Text] [Related]
16. Real-World Data from Nusinersen Treatment for Patients with Later-Onset Spinal Muscular Atrophy: A Single Center Experience.
Mendonça RH; Polido GJ; Matsui C; Silva AMS; Solla DJF; Reed UC; Zanoteli E
J Neuromuscul Dis; 2021; 8(1):101-108. PubMed ID: 33074187
[TBL] [Abstract][Full Text] [Related]
17. Cytochemical Characterization of Cerebrospinal Fluid Macrophage Inclusions in Pediatric Patients Receiving Intrathecal Nusinersen (SPINRAZA®) for Spinal Muscular Atrophy.
Schafernak KT; Jacobsen JR; Hernandez D; Kaye RD; Perez SE
Acta Cytol; 2022; 66(1):79-84. PubMed ID: 34515035
[TBL] [Abstract][Full Text] [Related]
18. Preliminary insights into RNA in CSF of pediatric SMA patients after 6 months of nusinersen.
Garofalo M; Bonanno S; Marcuzzo S; Pandini C; Scarian E; Dragoni F; Di Gerlando R; Bordoni M; Parravicini S; Gellera C; Masson R; Dosi C; Zanin R; Pansarasa O; Cereda C; Berardinelli A; Gagliardi S
Biol Direct; 2023 Sep; 18(1):57. PubMed ID: 37705059
[TBL] [Abstract][Full Text] [Related]
19. Nusinersen Administration Via an Intrathecal Port in a 16-Year-Old Spinal Muscular Atrophy Patient with Profound Scoliosis.
Flotats-Bastardas M; Linsler S; Zemlin M; Meyer S
Pediatr Neurosurg; 2020; 55(1):54-57. PubMed ID: 31722365
[TBL] [Abstract][Full Text] [Related]
20. Ultrasound-guided lumbar puncture for nusinersen administration in spinal muscular atrophy patients.
Veiga-Canuto D; Cifrián-Pérez M; Pitarch-Castellano I; Vázquez-Costa JF; Aparici F
Eur J Neurol; 2021 Feb; 28(2):676-680. PubMed ID: 33051940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
